Precision medicine: from academic centers to community practices
Biomarkers are revolutionizing the treatment landscape for NSCLC
The pathologist in cancer care
Are combination therapies the future of renal cell carcinoma treatment?
Using MammaPrint to select patients who may not need adjuvant chemotherapy – the results of MINDACT